Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Fully Utilizing Closed Systems in Modern BioPharma Facilities Lars Hovmand-Lyster and Ross Acucena Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department • Build... 3 years ago | 94 mins Single-Use Technologies - The Perspective of an End User Ciarán Kelleher & Barbara Paldus Today use of the term “single use technologies” can be considered as being synonymous with the modern biotech industries. Based on the proliferation o... 8 years ago | 66 mins Single-Use Technologies - The Perspective of an End User Ciaran Kelleher & Barbara Paldus Today use of the term ‚Äúsingle use technologies‚Äù can be considered as being synonymous with the modern biotech industries. Based on the proliferati... 8 years ago | 66 mins Vaccine Development & its Manufacturing using Integrated... Dr. S.K. Jana at Serum Institute of India Pvt. Ltd, Vikas Revankar at Merck and Piergiuseppe Nestola at Sartorius Full Title: Vaccine Development & its Manufacturing using Integrated High Throughput Technology The billions of doses of vaccines manufactured world... 2 years ago | 151 mins In Situ High Speed NIR Imaging to Monitor Form Change and Drug Release from... Patrick Wray, Senior Research Investigator, BMS and Miriam Böhmler, Senior Applications Scientist at WITec GmbH Full Title: In Situ High Speed NIR Imaging to Monitor Form Change and Drug Release from Rapidly Disintegrating Tablets Presented by Patrick Wray, Seni... 3 years ago | 76 mins Leveraging Smartphone Sensors to Measure Novel Health Outcomes Dr. Bill Byrom, Senior Director Product Innovation, ICON There has been a proliferation of sensors and components contained in modern smartphones, and we now have the ability to develop apps that can access ... 6 years ago | 62 mins Mass Spec - an Essential Tool for Characterization of mAbs during Development Dr Wei Xu & Dr Henry Shion Monoclonal antibodies (mAbs) represent a big portion of therapeutic proteins. Mass spectrometry (MS) coupled with modern separation technologies has b... 7 years ago | 75 mins Mass Spec - an Essential Tool for Characterization of mAbs during Development Dr Wei Xu & Dr Henry Shion Monoclonal antibodies (mAbs) represent a big portion of therapeutic proteins. Mass spectrometry (MS) coupled with modern separation technologies has b... 7 years ago | 75 mins Chemical patents: What can they tell us about failing drug discovery? Roshan Jumnah, Chemical IP Data Analyst at PatSnap Modern drug discovery appears in many ways to be well-defined with tried-and-tested approaches to acquire success. However, some research processes of... 5 years ago | 49 mins Designing production facilities of the future Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary Pigeau, Ph.D., Director at GE Healthcare Engineered autologous T cell products have proven to be an extremely promising new therapeutic modality, but they are currently time-consuming and cos... 4 years ago | 87 mins
